PARK2 Suppresses Proliferation and Tumorigenicity in Non-small Cell Lung Cancer

Aims: PARK2 mutation is originally associated with the progression of Parkinson's disease. In recent years, PARK2 has been reported as a tumor suppressor gene in various cancers, including lung cancer. However, the biological functions and potential molecular mechanisms of PARK2 in non-small ce...

Descripción completa

Detalles Bibliográficos
Autores principales: Duan, Huijie, Lei, Zhong, Xu, Fei, Pan, Tao, Lu, Demin, Ding, Peili, Zhu, Chunpeng, Pan, Chi, Zhang, Suzhan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6716169/
https://www.ncbi.nlm.nih.gov/pubmed/31508359
http://dx.doi.org/10.3389/fonc.2019.00790

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6716169/
https://www.ncbi.nlm.nih.gov/pubmed/31508359
http://dx.doi.org/10.3389/fonc.2019.00790

Ejemplares similares